USPH

Business Context and Reporting Period

Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: The Company operates 168 outpatient physical and occupational therapy clinics across 31 states, providing post-operative care and treatment for orthopedic and sports-related injuries. As of the reporting date, the Company also managed six third-party facilities.

Key Financial Metrics

*Note: Total debt consists of $3,000,000 in Convertible Subordinated Notes and $25,000 in notes payable. The Q1 2001 debt figure is derived from the balance sheet context where long-term notes were similar, though specific Q1 2001 total debt is not explicitly summed in the text.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 18% to $22.25 million, driven by a 15% increase in total patient visits (237,000 vs. 205,000). New clinics opened since Q1 2001 accounted for 64% of the revenue increase.
• Profitability: Net income rose 37% to $2.08 million. Operating income before non-operating expenses increased to $4.64 million from $3.81 million.
• Cost Management: Clinic operating costs as a percentage of revenue decreased from 69% to 68%. Salaries and related costs increased 19%, primarily due to new clinic openings and increased staffing at mature clinics.
• Liquidity: Cash and cash equivalents increased by $2.15 million to $10.27 million. The current ratio improved significantly to 16.64:1 from 6.83:1 at year-end 2001.
• Debt Reduction: Interest expense decreased 30% to $59,000 due to the conversion of $5.05 million of convertible subordinated debt into common stock in prior periods.

Guidance, Outlook, and Risks

• Expansion Goals: Management plans to open between 35 and 40 additional clinics in 2002. New clinics are expected to incur initial operating losses but will favorably impact results over the subsequent two to three years.
• Capital Strategy: The Company intends to fund operations and development through existing cash and operating cash flows. It generally develops clinics de novo rather than acquiring existing ones, though it may purchase minority interests in partnerships.
• Regulatory Risk (Medicare): A moratorium on the $1,500 annual Medicare reimbursement limit for therapy services is extended through December 31, 2002. Management does not anticipate a material impact if the limit becomes effective in 2003, as the Company does not generally treat long-term complicated rehabilitation cases.
• Accounting Changes: The Company adopted SFAS 142 in January 2002, ceasing the amortization of goodwill. An initial impairment test showed no impairment. Goodwill balance is $4.98 million.
• Weather Impact: Management noted that a mild winter in the north and northeast negatively impacted visit volume due to fewer weather-related injuries.

Investor Verification Checklist

• Cash Position: Verify the $10.27 million cash balance, noting that $6.01 million is held in a money market fund invested in U.S. Government short-term debt.
• Debt Obligations: Confirm the status of the $3.0 million Series C Convertible Subordinated Notes due June 30, 2004, and the conversion price of $3.33 per share.
• Minority Interest Acquisitions: Review the cash outflows related to the purchase of minority interests in Michigan clinics ($447,000 in Q1 2002 and $1.51 million in late 2001) and the associated undistributed earnings payments.
• Revenue Quality: Assess the allowance for doubtful accounts ($3.94 million) relative to patient accounts receivable ($13.8 million) to evaluate collection risks.
• Stock Dilution: Monitor the impact of stock option exercises ($1.36 million proceeds in Q1) and potential future conversions of the remaining subordinated debt on share count.